Franklin Street Advisors Inc Puma Biotechnology, Inc. Transaction History

Franklin Street Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $200,700 - $467,000	-10,000 Closed	0 $0
Q3 2018 Oct 05, 2018	SELL	$41.2 - $59.85 $412,000 - $598,500	-10,000 Reduced 50.0%	10,000 $459,000
Q2 2018 Jul 16, 2018	SELL	$48.3 - $68.25 $96,600 - $136,500	-2,000 Reduced 9.09%	20,000 $1.18 Million
Q3 2017 Oct 11, 2017	BUY	$72.0 - $119.75 $1.58 Million - $2.63 Million	22,000	22,000 $2.64 Million

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Franklin Street Advisors Inc with notifications on news.